Browse drugs

…16, 45.6% at W20, 44.3% at W24, and 56.4% at W52 with continued mirikizumab SC treatment, while CDAI clinical remission and PRO clinical re…

…Introduction Etrasimod is an oral, once-daily (QD), selective sphingosine 1-phosphate …

…am and fentanyl in increments of 1mg for Midazolam and 25μg for Fentanyl. This was administered by the sedationist (either trainee or tr…

… across groups and unrelated to study duration or AET. However, alphaONE™, particularly with 60sec suction, demonstrated significantly lo…

…t otherwise specified (PTCL-NOS). The disease was refractory to brentuximab vedotin plus cyclophosphamide, doxorubicin and prednisone, SMILE and pr…

… reinforcing drivers: perceived synergistic stimulation between khat and tobacco, deeply rooted social and cultural practices, progr…

…m baseline was +16.52 letters for 601 versus +17.79 letters for ranibizumab (adjusted mean difference: −1.27 letters (95% CI −5.439 to 2.89…

….5±5.7 mm.Conclusions This multicenter study suggests MMAE with Magic Glue may be a safe and effective alternative to established liquid e…

…th traumatic brain injury (TBI) who reported prehospital ASA or clopidogrel use. Patients were categorized BIG 1, 2, or 3 based on initial …

… cells/µL (n=49) was conducted.Results Sputum concentrations of Gal-10, ECP and EDN were weakly but significantly associated with radi…

…tching ASM. ASMs vary in their tendency to induce hyponatraemia—oxcarbazepine and carbamazepine have the highest risk—which is important to c…

…ined as diet alone or oral agents with no risk of hypoglycemia (metformin, dipeptidyl peptidase-4 inhibitors and sodium–glucose cotranspo…